WallStreetZenWallStreetZen

NASDAQ: KYMR
Kymera Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Kymera Therapeutics earnings were -$315.0M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest KYMR earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$69.2M, down 20.4% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, KYMR reported annual earnings of -$311.4M, with 39.1% growth.

KYMR earnings history

Current Revenue
$51.5M
Current Earnings
-$315.0M
Current Profit Margin
-612%

KYMR Return on Equity

Current Company
-25%
Current Industry
5.9%
Current Market
13.4%
KYMR's Return on Equity (-25%)... subscribe to Premium to read more.
High Return on Equity Performance

KYMR Return on Assets

Current Company
-22.3%
Current Industry
-1.8%
KYMR is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when KYMR announces earnings.

KYMR Return on Capital Employed

Current Company
-19.59%
Current Industry
5.4%
KYMR has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

KYMR vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
KYMR-$306.36M-$315.00MN/A-$3.58
TECH$226.43M$81.10M-14.59%$0.52
CELC-$159.73M-$177.04MN/A-$3.79
TGTX$134.18M$447.18M+486.89%$3.10
PTGX-$112.47M-$114.71MN/A-$1.81
View Top Biotech Stocks

Kymera Therapeutics Earnings Reports & History FAQ

What were Kymera Therapeutics's earnings last quarter?

On KYMR's earnings call on Invalid Date, Kymera Therapeutics (NASDAQ: KYMR) reported Q1 2026 earnings per share (EPS) of -$0.71, up 13.41% year over year. Total KYMR earnings for the quarter were -$69.23 million. In the same quarter last year, Kymera Therapeutics's earnings per share (EPS) was -$0.82.

If you're new to stock investing, here's how to buy Kymera Therapeutics stock.

Is Kymera Therapeutics profitable or losing money?

As of the last Kymera Therapeutics earnings report, Kymera Therapeutics is currently losing money. Kymera Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$315.00 million, a 30.77% increase year over year.

What was KYMR's earnings growth in the past year?

As of Kymera Therapeutics's earnings date in Invalid Date, Kymera Therapeutics's earnings has grown year over year. KYMR earnings in the past year totalled -$315.00 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.